Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the clinical status of patients who participated
in the original pivotal Betaseron study at 20 years after randomized treatment
initiationStudy end-points include:
1. Mortality - All-cause mortality - Cause specific mortality - Multiple sclerosis-related
mortality
2. EDSS (Expanded Disability Status Scale)
3. Cognition
4. Resource use
5. SPMS (Secondary Progressive Multiple Sclerosis) status
6. Employment history